New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 26, 2012
10:00 EDTACAT, OI, HBAN, AB, LAZ, TGT, STEL, EXPE, PG, PSX, MYL, CMEOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AllianceBernstein (AB) upgraded to Equal Weight from Underweight at Morgan Stanley... CME Group (CME) upgraded to Outperform from Market Perform at Raymond James... Expedia (EXPE) upgraded to Buy from Hold at Benchmark Co.... Expedia (EXPE) upgraded to Outperform from Market Perform at Raymond James... Huntington Bancshares (HBAN) upgraded to Buy from Neutral at Citigroup... Mylan (MYL) upgraded to Buy from Hold at Canaccord... StellarOne (STEL) upgraded to Strong Buy from Outperform at Raymond James... Owens-Illinois (OI) upgraded to Buy from Neutral at BofA/Merrill... Phillips 66 (PSX) upgraded to Outperform from Neutral at Credit Suisse... Target (TGT) upgraded to Buy from Neutral at Buckingham... Arctic Cat (ACAT) upgraded to Strong Buy from Buy at Felti... Proctor and Gamble (PG) upgraded to Outperform from Underperform at CLSA... Lazard (LAZ) upgraded to Neutral from Sell at Rochdale.
News For AB;CME;EXPE;HBAN;MYL;STEL;OI;PSX;TGT;ACAT;PG;LAZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
December 12, 2014
05:41 EDTLAZLazard upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette upgraded Lazard to Outperform with a $57 price target citing an improved outlook for 2015.
December 11, 2014
16:12 EDTACATArctic Cat initiated with a Neutral at Wedbush
Subscribe for More Information
13:36 EDTOIFollow-up: Owens-Illinois downgraded at Barclays
Subscribe for More Information
13:25 EDTOIOwens-Illinois downgraded to Equal Weight from Overweight at Barclays
10:13 EDTPGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:50 EDTPGProcter & Gamble initiated with a Market Perform at Raymond James
Subscribe for More Information
07:32 EDTMYLMylan launches generic version of Hikma Maple's Robaxin injection
Subscribe for More Information
07:06 EDTMYLMylan launches generic version of Orapred ODT
Mylan announced the U.S. launch of its Prednisolone Sodium Phosphate Orally Disintegrating Tablets, 10 mg, 15 mg, and 30 mg. This product is the first generic version of Shionogi's Orapred ODT. Mylan received final approval from the FDA for its Abbreviated New Drug Application for Prednisolone Sodium Phosphate Orally Disintegrating Tablets, 10 mg, 15 mg, and 30 mg, and was awarded 180 days of generic drug marketing exclusivity. This product is indicated as an anti-inflammatory or immunosuppressive agent for certain conditions; and also for the treatment of certain endocrine conditions, and for palliation of certain neoplastic conditions. Prednisolone Sodium Phosphate Orally Disintegrating Tablets had U.S. sales of approximately $19.9M for the 12 months ending September 30.
December 10, 2014
19:35 EDTCMECME Group declares annual variable dividend of $2.00 per share
Subscribe for More Information
16:50 EDTABAllianceBernstein reports Nov. AUM $481B
Subscribe for More Information
07:38 EDTMYLMylan launches generic version of Pfizer's Celebrex capsules
Mylan (MYL) announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic versions of Pfizer's (PFE) Celebrex Capsules, indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for the management of acute pain in adults. Celecoxib Capsules had U.S. sales of approximately $2.5B for the 12 months ending September 30, 2014.
December 9, 2014
10:23 EDTHBANOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:47 EDTEXPEExpedia management to meet with JMP Securities
Meeting to be held in Baltimore on December 11 hosted by JMP Securities.
06:43 EDTHBANHuntington Bancshares initiated with a Neutral at Guggenheim
05:55 EDTCMEStocks with implied volatility movement; CME SIRI
Subscribe for More Information
December 8, 2014
11:30 EDTMYLLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
10:00 EDTCMEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTEXPEEgencia and iJET strengthens global partnership
Subscribe for More Information
05:59 EDTCMECME Group downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette downgraded CME Group (CME) to Market Perform while upgrading NASDAQ (NDAQ) to Outperform.
05:58 EDTCMENASDAQ upgraded to Outperform from Market Perform at Keefe Bruyette
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use